Yoshihito Yokoyama (Yoshihito Yokoayama, Y Yokoyama)

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 23

Top Topics

Endometrial Cancer

Minimally Invasive

Top Venues

Journal of gynecologic oncology

Reproductive medicine and biology

Molecular biology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Kensuke Sakai, Wataru Yamagami, Yasunori Sato, Nobuyuki Susumu, Yoshihito Yokoyama, Kazuhiro Takehara, Masaki Mandai, Aikou Okamoto
A phase II trial evaluating the efficacy and safety of repeated high dose medroxyprogesterone acetate (MPA) therapy for patients with recurrent early-stage endometrial cancer or atypical endometrial hyperplasia: Japanese Gynecologic Oncology Group study (JGOG2051/KGOG2031, REMPA trial). Journal of gynecologic oncology (2024)
Takeshi Makabe, Wataru Yamagami, Fumiaki Takahashi, Hideki Tokunaga, Eiko Yamamoto, Yoshihito Yokoyama, Kiyoshi Yoshino, Kei Kawana, Satoru Nagase
Detailed report on the clinicopathological factors of patients with endometrial cancer in Japan: a JSOG gynecologic tumor registry-based study. Journal of gynecologic oncology 35 (4) (2024)
Daisuke Aoki, Tsutomu Tabata, Satoshi Yanagida, Toshiaki Nakamura, Asumi Okumura, Junzo Hamanishi, Kenichi Harano, Kosei Hasegawa, Takeshi Hirasawa, Kensuke Hori, Shinichi Komiyama, Motoki Matsuura, Hidekatsu Nakai, Hiroko Nakamura, Jun Sakata, Kazuhiro Takehara, Munetaka Takekuma, Yoshihito Yokoyama, Yoichi Kase, Shuuji Sumino, Junpei Soeda, Ai Kato, Ajit Suri, Aikou Okamoto, Toru Sugiyama
Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study. Journal of gynecologic oncology 35 (5) (2024)
Takeshi Makabe, Wataru Yamagami, Fumiaki Takahashi, Hideki Tokunaga, Eiko Yamamoto, Yoshihito Yokoyama, Kiyoshi Yoshino, Kei Kawana, Satoru Nagase
Detailed report on the clinicopathological factors of patients with endometrial cancer in Japan: a JSOG gynecologic tumor registry-based study. Journal of gynecologic oncology 35 (4) (2024)
Hiroaki Itamochi, Nobuhiro Takeshima, Junzo Hamanishi, Kosei Hasegawa, Motoki Matsuura, Kiyonori Miura, Shoji Nagao, Hidekatsu Nakai, Naotake Tanaka, Hideki Tokunaga, Shin Nishio, Hidemichi Watari, Yoshihito Yokoyama, Yoichi Kase, Shuuji Sumino, Ai Kato, Ajit Suri, Toshiaki Yasuoka, Kazuhiro Takehara
Niraparib in Japanese patients with platinum-sensitive recurrent ovarian cancer: final results of a multicenter phase 2 study. Journal of gynecologic oncology (2024)
Takeshi Makabe, Wataru Yamagami, Fumiaki Takahashi, Hideki Tokunaga, Eiko Yamamoto, Yoshihito Yokoyama, Kiyoshi Yoshino, Kei Kawana, Satoru Nagase
Detailed report on the clinicopathological factors of patients with endometrial cancer in Japan: a JSOG gynecologic tumor registry-based study. Journal of gynecologic oncology 35 (4) (2024)
Takeshi Makabe, Wataru Yamagami, Fumiaki Takahashi, Hideki Tokunaga, Eiko Yamamoto, Yoshihito Yokoyama, Kiyoshi Yoshino, Kei Kawana, Satoru Nagase
Detailed report on the clinicopathological factors of patients with endometrial cancer in Japan: a JSOG gynecologic tumor registry-based study. Journal of gynecologic oncology 35 (4) (2024)
Takeshi Makabe, Wataru Yamagami, Fumiaki Takahashi, Hideki Tokunaga, Eiko Yamamoto, Yoshihito Yokoyama, Kiyoshi Yoshino, Kei Kawana, Satoru Nagase
Detailed report on the clinicopathological factors of patients with endometrial cancer in Japan: a JSOG gynecologic tumor registry-based study. Journal of gynecologic oncology (2024)
Yosuke Konno, Michinori Mayama, Kazuhiro Takehara, Yoshihito Yokoyama, Jiro Suzuki, Nobuyuki Susumu, Kenichi Harano, Satoshi Nakagawa, Toru Nakanishi, Wataru Yamagami, Kosuke Yoshihara, Hiroyuki Nomura, Aikou Okamoto, Daisuke Aoki, Hidemichi Watari
Prognostic impact of the number of resected pelvic nodes in endometrial cancer: Japanese Gynecologic Oncology Group Study JGOG2043 post hoc analysis. Journal of gynecologic oncology (2024)
Hiroaki Komatsu, Osamu Hiraike-Wada, Rie Fukuhara, Yoshihito Yokoyama, Nobutaka Takahashi, Hirotaka Nishi, Tsukasa Baba, Takuma Fujii, Jo Kitawaki, Hiroaki Kobayashi, Masaki Mandai, null null
Is there a need for a technical certification system for gynecological robotic surgery? Questionnaire survey of members of the Japan Society of Gynecologic and Obstetric Endoscopy and Minimally Invasive Therapy. Journal of robotic surgery (2023)
Takayuki Nagasawa, Tadahiro Shoji, Eriko Takatori, Yoshitaka Kaido, Masahiro Kagabu, Dai Shimizu, Tatsuhiko Shigeto, Tsukasa Baba, Toru Sugiyama, Yoshihito Yokoyama
A Phase II Study of S-1 plus Oxaliplatin for Patients with Recurrent Non-Squamous Cell Carcinoma of the Uterine Cervix (Tohoku Gynecologic Cancer Unit: TGCU206 Study). Cancers 15 (21) (2023)
Toshiyuki Seki, Atsumi Kojima, Shinichi Okame, Satoshi Yamaguchi, Aikou Okamoto, Hideki Tokunaga, Shin Nishio, Yuji Takei, Yoshihito Yokoyama, Manabu Yoshida, Norihiro Teramoto, Yoshiki Mikami, Muneaki Shimada, Junzo Kigawa, Kazuhiro Takehara
Poor Treatment Outcomes of Locally Advanced Cervical Adenocarcinoma of Human Papilloma Virus Independent Type, Represented by Gastric Type Adenocarcinoma: A Multi-Center Retrospective Study (Sankai Gynecology Study Group). Cancers 15 (6) (2023)
Toshiyuki Seki, Atsumi Kojima, Shinichi Okame, Satoshi Yamaguchi, Aikou Okamoto, Hideki Tokunaga, Shin Nishio, Yuji Takei, Yoshihito Yokoyama, Manabu Yoshida, Norihiro Teramoto, Yoshiki Mikami, Muneaki Shimada, Junzo Kigawa, Kazuhiro Takehara
Poor Treatment Outcomes of Locally Advanced Cervical Adenocarcinoma of Human Papilloma Virus Independent Type, Represented by Gastric Type Adenocarcinoma: A Multi-Center Retrospective Study (Sankai Gynecology Study Group). Cancers 15 (6) (2023)
Minako Yokoyama, Toshitsugu Fujita, Yuka Kadonosawa, Yota Tatara, Daisuke Motooka, Masahito Ikawa, Hodaka Fujii, Yoshihito Yokoyama
Development of transgenic mice overexpressing mouse carbonyl reductase 1. Molecular biology reports (2022)
Kayo Horie, Naoki Nanashima, Yoshihito Yokoyama, Haruhiko Yoshioka, Jun Watanabe
Exosomal MicroRNA as Biomarkers for Diagnosing or Monitoring the Progression of Ovarian Clear Cell Carcinoma: A Pilot Study. Molecules (Basel, Switzerland) 27 (12) (2022)
Yuya Nogami, Hiroaki Komatsu, Takeshi Makabe, Yuri Hasegawa, Yoshihito Yokoyama, Kei Kawana, Aikou Okamoto, Mikio Mikami, Hidetaka Katabuchi, null null
Impact of COVID-19 on gynecologic cancer treatment in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO). Journal of gynecologic oncology (2021)
Kazuhiro Takehara, Takashi Matsumoto, Junzo Hamanishi, Kosei Hasegawa, Motoki Matsuura, Kiyonori Miura, Shoji Nagao, Hidekatsu Nakai, Naotake Tanaka, Hideki Tokunaga, Kimio Ushijma, Hidemichi Watari, Yoshihito Yokoyama, Yoichi Kase, Shuuji Sumino, Ajit Suri, Hiroaki Itamochi, Nobuhiro Takeshima
Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-sensitive relapsed ovarian cancer. Journal of gynecologic oncology 32 (2) (2021)
Hideki Tokunaga, Mikio Mikami, Satoru Nagase, Yoichi Kobayashi, Tsutomu Tabata, Masanori Kaneuchi, Toyomi Satoh, Yasuyuki Hirashima, Noriomi Matsumura, Yoshihito Yokoyama, Kei Kawana, Satoru Kyo, Daisuke Aoki, Hidetaka Katabuchi
The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer. Journal of gynecologic oncology 32 (2) (2021)
Aikou Okamoto, Asumi Okumura, Toshiaki Nakamura, Satoshi Yanagida, Junzo Hamanishi, Kenichi Harano, Kosei Hasegawa, Takeshi Hirasawa, Kensuke Hori, Shinichi Komiyama, Motoki Matsuura, Hidekatsu Nakai, Hiroko Nakamura, Jun Sakata, Tsutomu Tabata, Kazuhiro Takehara, Munetaka Takekuma, Yoshihito Yokoyama, Yoichi Kase, Shuuji Sumino, Junpei Soeda, Ajit Suri, Daisuke Aoki, Toru Sugiyama
Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer. Journal of gynecologic oncology 32 (2) (2020)
Fumie Oyama, Masayuki Futagami, Tatsuhiko Shigeto, Rie Miura, Yuuki Osawa, Maika Oishi, Hiroe Oikiri, Minako Yokoyama, Anna Takabayashi, Yoshihito Yokoyama
Preventive effect of daikenchuto, a traditional Japanese herbal medicine, on onset of ileus after gynecological surgery for malignant tumors. Asia-Pacific journal of clinical oncology 16 (4) (2020)
Hiroe Oikiri, Yoshiya Asano, Michiya Matsusaki, Mitsuru Akashi, Hiroshi Shimoda, Yoshihito Yokoyama
Inhibitory effect of carbonyl reductase 1 against peritoneal progression of ovarian cancer: evaluation by ex vivo 3D-human peritoneal model. Molecular biology reports 46 (5) (2019)
Aisa Yamauchi, Asami Kobayashi, Hiroe Oikiri, Yoshihito Yokoyama
Functional role of the Tau protein in epithelial ovarian cancer cells. Reproductive medicine and biology 16 (2) (2017)
Hiroshi Tsuda, Yoichi M Ito, Yukiharu Todo, Takahiro Iba, Keiichi Tasaka, Yuji Sutou, Kozo Hirai, Koichiro Dozono, Yoshifusa Dobashi, Mami Manabe, Tomomi Sakamoto, Ritsu Yamamoto, Katsufumi Ueda, Moe Akatsuka, Yasuhiko Kiyozuka, Nobutaka Nagai, Manami Imai, Koji Kobiki, Hiromasa Fujita, Hiroaki Itamochi, Takafumi Oshita, Takahiro Kawarada, Masayuki Hatae, Yoshihito Yokoyama
Measurement of endometrial thickness in premenopausal women in office gynecology. Reproductive medicine and biology 17 (1) (2017)
A Kobayashi, Yoshihito Yokoyama, Y Osawa, R Miura, H Mizunuma
Gene therapy for ovarian cancer using carbonyl reductase 1 DNA with a polyamidoamine dendrimer in mouse models. Cancer gene therapy 23 (1) (2015)